Sjögren’s syndrome (SS) is a representative autoimmune disease characterized by exocrine dysfunction and the appearance of anti-Ro/SS-A and La/SS-B antibodies, which are produced by T cell activation and subsequent B cell proliferation [1,2,3]. This evidence concerns the gene SSB and synovial sarcoma.